SONG, X. Targeting of both PI3K/Akt/mTOR pathway and mutant EGFR to overcome resistance to tyrosine kinase inhibitors in mutant EGFR-mediated lung cancer. Onco Reviews, v. 1, n. 1, p. pp.13–19, 1 Nov.2013.